eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2020
vol. 37
 
Share:
Share:
Review paper

Compression therapy in venous diseases: physical assumptions and clinical effects

Andrzej Berszakiewicz
1, 2
,
Aleksander Sieroń
3
,
Zbigniew Krasiński
4
,
Armand Cholewka
5
,
Agata Stanek
3

1.
Department of Internal Medicine, Angiology and Physical Medicine, Specialist Hospital No. 2, Bytom, Poland
2.
Fresenius Dialysis Centre No. 38 in Oswiecim, Fresenius Nephrocare Polska, Oswiecim, Poland
3.
Department of Internal Medicine, Angiology and Physical Medicine, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Bytom, Poland
4.
Department of General and Vascular Surgery, Poznan University of Medical Sciences, Poznan, Poland
5.
Department of Medical Physics, Chelkowski Institute of Physics, University of Silesia, Katowice, Poland
Adv Dermatol Allergol 2020; XXXVII (6): 842–847
Online publish date: 2019/07/26
Article file
Get citation
 
 

Introduction

Chronic venous disease (CVD) is associated with significant morbidity and burden to the patients, society and healthcare system [1]. In the US, the venous leg ulceration is associated with the annual treatment cost of over USD 3 billion [2, 3]. In Western Europe, the CVD treatment cost amounts to 1–2% of annual health budget in individual countries [4]. The magnitude of CVD-associated problems and costs is ever increasing. In the United States, where the healthcare system aims at reducing the cost of medical procedures, the expenses for the treatment of CVD-associated complications cannot be cut down and due to the absence of uniform standards for CVD treatment, treatment costs are now transferred on the affected patients [5]. Therefore, choosing the optimum treatment and developing management standards appear crucial. Compression therapy (CT) is a basic treatment for venous and lymphatic disorders.

Physical assumptions of compression therapy

Compression therapy works by exerting external pressure on lower extremities and preventing the gravity which impairs venous and lymphatic outflow. Compression therapy aims at preventing intraluminal venous pressure increase so as to reduce vascular wall tension [6, 7]. The CT works in accordance with Laplace’ law and Pascal’ law. Laplace’ law describes the relationships between forces acting in spherical and cylindrical vessels. According to the Laplace’ law, the tension of the vascular wall increases along with the pressure across the vessel wall [8]. The Laplace’ law enables computing surface pressure exerted by a textile placed onto a surface of a cylindrical vessel [7]. The compression force exerted by a compression textile is directly proportional to its tension, and inversely proportional to the radius of the leg. It is expressed by the following equation: P = T/R, where P – pressure under the textile, T – tension of compression textile, R – leg radius.
In multilayer compression systems, the P value is calculated using the modified Laplace equation, which uses the tension of each layer, number of layers, leg circumference and bandage width. It is expressed by the following equation: P = (T × number of layers × 4620)/(leg circumference (cm) × bandage width (cm)) [9].
The Pascal’ law, on the other hand, describes pressure distribution in an incompressible fluid-filled container surrounded by stiff material. It assumes that the pressure will be equally distributed in the covered compartment [10]. This occurs, for example, within the soft tissue of the bandaged leg if stiff, non-tensile compression systems are used, when muscles contract under a textile layer [9].
Properties of textiles are characterized using specific parameters which enable their optimum selection for CVD severity. They include stiffness, elasticity, static and dynamic stiffness indices as well as surface tension generated when applying the textile [11].

Stiffness

Stiffness is the ability of a textile to resist deformation under stress. It describes the relationship between the tensile force and textile stretch. Stiffness is the key property to differentiate between elastic and inelastic materials [10] According to the European Committee for Standardisation (Centre Europeen de Normalisation, CEN), stiffness is defined as the pressure increase produced by muscle contraction per centimetre of increase in leg circumference, expressed in hectopascals per centimetre and/or millimetres of mercury per centimetre [10–12]. Measurements of stiffness are performed in textile laboratories using extensometers on a mannequin leg designed by Hirai et al. The pressure increase produced by medical compression hosiery (MCH) per centimetre of increase in leg circumference corresponds to the CEN’s definition of stiffness [12]. Stiffness classification according to CEN identifies three stiffness classes (Table 1) [10].
In vivo measurements are performed at the B1 point, 10–15 cm above the medial malleolus, at the segment where at the medial side of the leg, the muscular part of the gastrocnemius muscle turns into the tendinous part. The B1 point is the area which shows the maximal extension during movement, ranging from several millimetres to 1.5 cm [12, 13].

Elasticity

Elasticity is the textile’s ability to return to its original size after the pressure has been reduced [14]. Most materials used for compression therapy are elastic to some extent. However, there are also inelastic ones, such as zinc paste bandages or rigid Velcro straps [7, 15]. Elasticity depends on the presence of basal fibres, such as latex or elastane (Lycra), and functional properties of the material [16]. Maximal stretch is the deciding parameter for differentiating elastic and inelastic compression materials. Thus, the materials of maximal stretch above 100% are considered elastic and those of maximal stretch of 10–100% are considered inelastic [10, 17]. A more detailed classification, though, differentiates between four categories of materials (Table 2)[15]. This simple concept may still be valid for the differentiation of a single bandage product. However, it does not apply to multicomponent or elastic-inelastic complex compression systems [10]. The elastic properties of the material determine its effect on the pressure at standing and in the supine resting position as well as working pressure generated during walk, when muscle contraction and dynamic changes in leg circumference lead to an increase in pressure under the compression material [2, 11, 12]. The pressure generated underneath the elastic material during walking can be compared with the standing pressure, which is only slightly higher than the resting pressure [10, 17, 18]. Inelastic materials, due to their high stiffness and low elasticity, generate high systolic pressure peaks during walking and exercise and low resting pressure [17, 18]. Owing to such properties, inelastic compression materials are able to improve the venous pump more effectively than elastic materials [18, 19].

Interface pressure

Interface pressure (IP) is a pressure at the interface of two surfaces. In CT, it is the pressure between the compression device and skin [18]. It is the pressure exerted by compression material on the leg [20]. Interface pressure is a direct effect of elasticity of the compression material and muscle activity [10, 12, 20]. Thus, IP describes a dose of compression therapy which correlates with its clinical effectiveness. The relationship between them is not always linear [12]. Owing to standardized IP measurement, it is possible to compare and develop new compression systems as well as to select the optimum compression option for individual clinical situations. IP is measured under the compression layer, preferably at the B1 point [18, 21, 22]. Commercially available measurement devices include Picopress (Microlabitalia, Padua, Italy) and Kikuhime (Meditrade, Soro, Denmark) as well as piezoresistive pressure sensors. Both types offer a comparable measurement accuracy [22]. There are also newer devices which enable real-time IP measurement. This principle has been used to develop a functional prototype smart bandage (SB) into which silver strain gauge transducers are knitted. A connection point and digital electronics to detect the transducer output are located at a bandage extremity. These wirelessly connect to a user interface (a Bluetooth user interface, for example a smartphone or tablet) with an app that reports the values of applied pressure in real time [6].
Choosing appropriate IP along with its maintenance are the key to effective compression treatment. The level of compression should be adjusted to symptom severity and limited with the value of the minimum effective compression [23]Adequate compression ensures the optimum clinical benefit, what is presented in Table 3. For the external compression to affect venous haemodynamic in the upright position, the interface pressure should exceed intravenous pressure ranging between 60 and 100 mm Hg [10, 24, 25]. However, long-term continuous external compression above 60–70 mm Hg may cause tissue damage. As a consensus, it was therefore accepted that optimum compression therapy depends on the body position and mimics physiological pressure distribution, with the lowest possible resting pressure and short, high pressure spikes generated during walking [2, 10].
Different compression therapy forms deliver target interface pressure in different ways. For example, the interface pressure and compression profiles of compression hosiery are provided by the manufacturer. With bandage, it is more difficult to achieve and maintain the target interface pressure. Bandaging is subjective and depends on the skills of the person as well as the force they use for bandaging. To a lesser extent, it also depends on elastic properties of the bandage and the number of layers. Furthermore, as the leg circumference decreases, it is more difficult to maintain constant interface pressure, which is why it (and, as a result, the effective compression dose, as well) cannot be precisely determined in most cases [14, 26–28]. On the other hand, the intermittent pneumatic compression (IPC) devices offer predefined compression and interface pressure. The settings are either fixed or individually selected depending on venous filling time. The compression force may be applied either uniformly to the calf using a single chamber device or through a series of chambers inflated in a sequential manner from the ankle to thigh [29, 30]. It is also possible to control pressure values independently in individual chambers [31]. The adjustable Velcro compression devices (AVCDs) ensure maintenance of optimum interface pressure by using a special in-built/built-in compression measurement system [32, 33]. Another device which ensures constant resting interface pressure all day long is the Lundatex compression system (PressCise, Herrljunga, Sweden) which has been used in research. It consists of two components, the Lundatex® medical bandage, which provides a safe and well-defined resting pressure owing to a cross-line indicator system, and two velcro products called PressPatch™ and FixPatch™. Adding stiff velcro products not only turns an elastic bandage into an inelastic compression device, but also enables hassle-free maintenance of target interface pressure by readjusting the FixPatch, without the need to re-bandage [19, 26].

Static Stiffness Index

The Static Stiffness Index(SSI)has been proposed as a parameter for assessing the elasticity (stiffness) of a compression device in vivo. The SSI is the difference between standing pressure and resting pressure. Both measurements are taken at the B1 point [10, 12]. For the resting pressure measurement, the measuring site is on the leg at the heart level with relaxed knee and ankle joint. For the standing pressure, the measurement is taken 2–3 min after standing up and after the leg veins are filled. SSI over 10 denotes a high stiffness and inelasticity of the compression material/system. The Static Stiffness Indexbelow 10 denotes a low stiffness and elasticity of the compression material/system [10, 20]. The SSI of compression hosiery is usually low, below 5 [10]. It depends on the properties of yarn, which determine the thickness and stiffness of the compression product as well as the type of knit, usually higher in thicker and stiffer, flat knit products [16]. Flat knit compression hosiery can offer SSI above 10. Increase in SSI can be explained by the elastic properties of the compression material, the number of layers and friction between the layers. Four-layer bandages showed an SSI value of 15 as regards inelastic bandages, and SSI values measured under a zinc-paste bandage can reach even 40 mm Hg. The Static Stiffness Index depends not only on the type of material but also on anatomy and muscle strength. It will, therefore, be higher, in individuals with well-developed musculature as compared to slim, asthenic or obese ones as well as those with lymphoedema [10].

Dynamic Stiffness Index (DSI)

The Dynamic Stiffness Index (DSI), estimated during walking, describes the coexistence of dynamic changes in leg circumference and IP. The importance of DSI can be explained by hysteresis, that is, the effect of the preceding condition of the system on its current condition. When applied to compression therapy, it means delayed response of material fibres to an external factor, such as muscle stretch-relaxation. During a normal walking speed, the elastic elongation of compression hosiery is unable to keep up with the circumferential changes of the leg. As a result, the IP rises when leg muscles contract and drops when they relax. This phenomenon is known as the massaging effect with pressure peaks during walking, which determine the clinical efficacy of a compression product [12]. DSI measurement is used for research purposes. It is measured on a mannequin leg during simulated gait at the frequency of 1 Hz (1 Hz = 1 gait cycle per second). DSI estimation in vivo is difficult, due to high variability of leg circumference changes at point B1 during walk. Therefore, static measurements including IP and SSI are preferred for daily practice rather than dynamic ones [10, 12, 13].

Clinical effects

Clinical effects of compression are shown in Table 4 [34–37].

Contraindications to compression therapy

Despite obvious clinical benefits, not all patients are eligible for compression therapy. The list of contraindications to compression therapy has been getting ever shorter. Some of once absolute contraindications have become relative contraindications (Table 5). An example is lower extremity artery disease (LEAD), with ABPI < 0.8, which is currently considered a relative contraindication to compression therapy. Using compression therapy in such cases requires extensive experience. Another example is leg deformity. As it is now possible to manufacture compression products individually fitted to the size and shape of the extremity alongside using cushions and pads, leg deformity has become a relative contraindication. However, standard compression stockings cannot be used as it is impossible to reliably determine the actual compression applied onto the deformed areas [23, 24].

Conclusions

A close link between chronic venous disease, civilisation-related factors and population aging results in increasing prevalence of CVD worldwide, whereas low public awareness of its chronic, progressive nature and complications delay prevention and treatment. CT is an established treatment method in chronic venous disease. Its key element involves educating the staff, the patients and their relatives in order to ensure their full involvement and compliance. CT works by exerting external, anti-gravity pressure on lower extremities, which improves the impaired venous outflow. Despite years of clinical experience, choosing optimum compression therapy, including grade and pressure distribution, which determine the efficacy of treatment, still poses a challenge.

Acknowledgments

The authors would like to thank Prof. Hugo Partsch for priceless remarks.

Conflict of interest

The authors declare no conflict of interest.
Copyright: © 2019 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.